Stage at diagnosis and ovarian cancer survival: Evidence from the international cancer benchmarking partnership

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 75-82

  Maringe, Camille ^a   Walters, Sarah ^a   Butler, John ^b   Coleman, Michel P ^a   Hacker, Neville ^c   Hanna, Louise ^d   Mosgaard, Berit J ^e   Nordin, Andy ^f   Rosen, Barry ^g   Engholm, Gerda ^h   Gjerstorff, Marianne L ⁱ   Hatcher, Juanita ^j   Johannesen, Tom B ^k   McGahan, Colleen E ^l   Meechan, David ^m   Middleton, Richard ⁿ   Tracey, Elizabeth ^o   Turner, Donna ^p   Richards, Michael A ^q   Rachet, Bernard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Velindre NHS Trust   (United Kingdom)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF TORONTO   (Canada)

^h DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁱ Danish Cancer Registry   (Denmark)

^j ALBERTA HEALTH SERVICES   (Canada)

^k CANCER REGISTRY OF NORWAY   (Norway)

^l BRITISH COLUMBIA CANCER AGENCY   (Canada)

^m Trent Cancer Registry   (United Kingdom)

ⁿ Northern Ireland Cancer Registry   (United Kingdom)

^o CANCER INSTITUTE NSW   (Australia)

^p CANCERCARE MANITOBA   (Canada)

^q Portland House   (United Kingdom)

more..

Author keywords

Cancer survival; International; Ovary; Stage

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUSTRALIA; CANADA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; DELAYED DIAGNOSIS; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NORWAY; OVARY CANCER; PRIORITY JOURNAL; UNITED KINGDOM;

AGED; AUSTRALIA; CANADA; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NORWAY; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84865697215     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.033     Document Type: Article

References (21)

1. M.P. Coleman, D. Forman, H. Bryant, J. Butler, B. Rachet, and C. Maringe Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Lancet 377 2011 127 138
2. S. Walters, C. Maringe, J. Butler, J.D. Brierley, B. Rachet, and M.P. Coleman Comparability of stage data in cancer registries in six countries: lessons from the international cancer benchmarking partnership Int J Cancer 2012 [epub ahead of print]
3. L.H. Sobin, M. Gospodarowicz, and C. Wittekind TNM classification of malignant tumours 7 ed. 2009 Union for International Cancer Control (UICC), Wiley-Blackwell Oxford
4. J.L. Young, S.D. Roffers, L.A.G. Ries, A.G. Fritz, and A.A. Hurlbut SEER Summary Staging Manual - 2000: Codes and Coding Instructions 2001 National Cancer Institute Bethesda
5. P.C. Lambert, and P. Royston Further development of flexible parametric models for survival analysis Stata J 9 2 2009 265 290
6. M. Pohar-Perme, J. Stare, and J. Estève On estimation in relative survival Biometrics 68 1 2012 113 120
7. P. Royston Multiple imputation of missing values: update of ice Stata J 5 2005 527 536
8. U. Nur, L.G. Shack, B. Rachet, J.R. Carpenter, and M.P. Coleman Modelling relative survival in the presence of incomplete data: a tutorial Int J Epidemiol 39 2010 118 128
9. I.R. White, P. Royston, and A.M. Wood Multiple imputation using chained equations: issues and guidance for practice Stat Med 30 4 2011 377 399
10. S.C. Erridge, H. Moller, A. Price, and D. Brewster International comparisons of survival from lung cancer: pitfalls and warnings Nat Clin Pract Oncol 4 10 2007 570 577
11. R.J. Kurman, and I.M. Shih The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 3 2010 433 443
12. K.M. Schmeler, and D.M. Gershenson Low-grade serous ovarian cancer: a unique disease Curr Oncol Rep 10 6 2008 519 523
13. I. Lataifeh, D.E. Marsden, G. Robertson, V. Gebski, and N.F. Hacker Presenting symptoms of epithelial ovarian cancer Aust N Z J Obstet Gynaecol 45 3 2005 211 214
14. C.M. Nagle, J.E. Francis, A.E. Nelson, H. Zorbas, K. Luxford, and A. de Fazio Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: A report from the Australian Ovarian Cancer Study Group J Clin Oncol 29 16 2011 2253 2258
15. G. Zanetta, S. Rota, S. Chiari, C. Bonazzi, G. Bratina, and V. Torri The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma Ann Oncol 9 10 1998 1097 1101
16. C. Marx, A. Bendixen, C. Hogdall, C. Ottosen, H. Kehlet, and B. Ottesen Organisation and quality of primary surgical intervention for ovarian cancer in Denmark Acta Obstet Gynecol Scand 86 12 2007 1496 1502
17. M. Sant, C. Allemani, R. Capocaccia, T. Hakulinen, T. Aareleid, and J.W.W. Coebergh Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe Int J Cancer 106 2003 416 422
18. J. Engel, R. Eckel, G. Schubert-Fritschle, J. Kerr, W. Kuhn, and J. Diebold Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate Eur J Cancer 38 19 2002 2435 2445
19. C.L. Kosary Chapter 16, Cancer of the ovary L.A.G. Ries, J.L. Young, G.E. Keel, M.P. Eisner, Y.D. Lin, M.-J. Horner, SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program 2007 133 144
20. Australian Institute of Health and Welfare and National Breast and Ovarian Cancer Centre Ovarian cancer in Australia, and overview 2010 Feb. 2010 AIHW Canberra Cat. no. CAN 48
21. C.G. Hannibal, R. Cortes, G. Engholm, and S.K. Kjaer Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002 Acta Obstet Gynecol Scand 87 12 2008 1353 1360